Welldoc receives additional FDA approval for digital diabetes solution

Michael Walter | | Cardiovascular Business | Heart Health
approved approval

Welldoc, a Columbia, Maryland-based digital health company, has gained an additional FDA approval for its BlueStar diabetes management solution.

This most recent approval covers BlueStar’s Insulin Adjustment Program (IAP) feature, which automatically makes needed insulin dose adjustments for adult patients with type 2 diabetes. According to Mansur Shomali, MD, Welldoc’s chief medical officer, this feature helps patients receive the care they need as soon as they need it and can lead to more productive conversations with physicians.

“With BlueStar's IAP, a provider prescribes a safe starting dose of insulin for his or her patient, and BlueStar does the rest,” Shomali said in a prepared statement. “The patient no longer has to wait to talk to his or her provider to adjust the insulin. The next time the patient meets with his or her health care provider, the insulin dose has been optimized and they can spend their visit focusing on other important elements of the patient's care.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Medtronic receives key FDA clearance, launches new diabetes system
Martha Gulati highlights 'exciting' progress in preventive cardiology
Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment
Cardiologist examines the latest breakthroughs in coronary inflammation research
Tirzepatide linked to significant weight loss, ‘impressive’ diabetes prevention after 3 years
No-contact blood pressure and diabetes screening with AI shows promise

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."